ORGO 3.28 (+0.61%)
US68621F1021Drug ManufacturersDrug Manufacturers - Specialty & Generic

Organogenesis Holdings (ORGO) Financial Metrics

This table shows a selected set of financial data points of Organogenesis Holdings (ORGO). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 0.04 0 108.49 536.74M 0.01 433.14M 6.55M 36.03M 4.95M 103.84M
2022 0.12 0 22.53 349.89M 0.03 450.89M -9.04M 40.32M 15.53M 102.48M
2021 0.73 0 12.59 1.19B 0.26 467.36M 30.76M 88.88M 94.2M 113.93M
2020 0.16 0 47.06 811.27M 0.07 338.3M -12.21M 34.98M 17.23M 84.39M
2019 -0.44 0 -11.04 446.56M -0.21 260.98M -39.76M -20.02M -40.45M 60.17M
2018 -0.94 0 -10.85 703.58M -0.27 193.45M -62.6M -46.92M -64.83M 21.29M
2017 -0.22 0 -44.23 92.6M -0.01 0 -586.6K 404.01K -2.09M 125.89K
2016 -0.03 0 0 0 -0 0 -562.23K -208.7K -208.7K 1.04M
2015 -0 0 0 0 -0.02 98.98M 0 0 -25.16K 126.06K
2001 0 0 0 0 0 1.04M 0 0 -2.88M 199.36K

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.